Effects of protamine administration after cardiopulmonary bypass on complement, blood elements, and the hemodynamic state. 1986

J K Kirklin, and D E Chenoweth, and D C Naftel, and E H Blackstone, and J W Kirklin, and D D Bitran, and J G Curd, and J G Reves, and P N Samuelson

Nineteen patients were prospectively selected and studied before and after the administration of protamine sulfate following cardiopulmonary bypass (CPB). After protamine administration, C3a, C4a, and C4d were elevated; the peak levels of C3a and C4a were in samples taken 10 minutes after protamine administration while those of C4d were in those obtained at 5 hours. Only C3a was elevated after CPB and before protamine administration. In vitro, only the combination of protamine sulfate and heparin, and neither alone, resulted in increased C3a and C4a. Administration of protamine was associated with small and transient decreases in total white blood cells, granulocytes, and platelets, and with small and transient reductions in systemic and pulmonary arterial and left and right atrial pressures. Systemic vascular resistance fell (p = 0.07), and pulmonary vascular resistance rose but the change could be due to chance (p = 0.29). These data and those reported by others support the inference that complement activation occurs during CPB by the alternative pathway and again during protamine administration by the classic pathway; and that this accompanies a whole-body inflammatory reaction with blood cell and hemodynamic changes which, when extreme, could result in a severe hemodynamic derangement.

UI MeSH Term Description Entries
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011479 Protamines A group of simple proteins that yield basic amino acids on hydrolysis and that occur combined with nucleic acid in the sperm of fish. Protamines contain very few kinds of amino acids. Protamine sulfate combines with heparin to form a stable inactive complex; it is used to neutralize the anticoagulant action of heparin in the treatment of heparin overdose. (From Merck Index, 11th ed; Martindale, The Extra Pharmacopoeia, 30th ed, p692) Protamine,Protamine Sulfate,Protamine Chloride,Chloride, Protamine,Sulfate, Protamine
D001772 Blood Cell Count The number of LEUKOCYTES and ERYTHROCYTES per unit volume in a sample of venous BLOOD. A complete blood count (CBC) also includes measurement of the HEMOGLOBIN; HEMATOCRIT; and ERYTHROCYTE INDICES. Blood Cell Number,Blood Count, Complete,Blood Cell Counts,Blood Cell Numbers,Blood Counts, Complete,Complete Blood Count,Complete Blood Counts,Count, Blood Cell,Count, Complete Blood,Counts, Blood Cell,Counts, Complete Blood,Number, Blood Cell,Numbers, Blood Cell
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002315 Cardiopulmonary Bypass Diversion of the flow of blood from the entrance of the right atrium directly to the aorta (or femoral artery) via an oxygenator thus bypassing both the heart and lungs. Heart-Lung Bypass,Bypass, Cardiopulmonary,Bypass, Heart-Lung,Bypasses, Cardiopulmonary,Bypasses, Heart-Lung,Cardiopulmonary Bypasses,Heart Lung Bypass,Heart-Lung Bypasses
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D003167 Complement Activation The sequential activation of serum COMPLEMENT PROTEINS to create the COMPLEMENT MEMBRANE ATTACK COMPLEX. Factors initiating complement activation include ANTIGEN-ANTIBODY COMPLEXES, microbial ANTIGENS, or cell surface POLYSACCHARIDES. Activation, Complement,Activations, Complement,Complement Activations
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J K Kirklin, and D E Chenoweth, and D C Naftel, and E H Blackstone, and J W Kirklin, and D D Bitran, and J G Curd, and J G Reves, and P N Samuelson
January 1992, Scandinavian journal of thoracic and cardiovascular surgery,
J K Kirklin, and D E Chenoweth, and D C Naftel, and E H Blackstone, and J W Kirklin, and D D Bitran, and J G Curd, and J G Reves, and P N Samuelson
March 1984, The Annals of thoracic surgery,
J K Kirklin, and D E Chenoweth, and D C Naftel, and E H Blackstone, and J W Kirklin, and D D Bitran, and J G Curd, and J G Reves, and P N Samuelson
June 1991, Anesthesiology,
J K Kirklin, and D E Chenoweth, and D C Naftel, and E H Blackstone, and J W Kirklin, and D D Bitran, and J G Curd, and J G Reves, and P N Samuelson
September 1985, Surgery,
J K Kirklin, and D E Chenoweth, and D C Naftel, and E H Blackstone, and J W Kirklin, and D D Bitran, and J G Curd, and J G Reves, and P N Samuelson
March 1983, Anaesthesia,
J K Kirklin, and D E Chenoweth, and D C Naftel, and E H Blackstone, and J W Kirklin, and D D Bitran, and J G Curd, and J G Reves, and P N Samuelson
February 1993, Anaesthesia and intensive care,
J K Kirklin, and D E Chenoweth, and D C Naftel, and E H Blackstone, and J W Kirklin, and D D Bitran, and J G Curd, and J G Reves, and P N Samuelson
January 2016, Scandinavian cardiovascular journal : SCJ,
J K Kirklin, and D E Chenoweth, and D C Naftel, and E H Blackstone, and J W Kirklin, and D D Bitran, and J G Curd, and J G Reves, and P N Samuelson
September 1974, Thorax,
J K Kirklin, and D E Chenoweth, and D C Naftel, and E H Blackstone, and J W Kirklin, and D D Bitran, and J G Curd, and J G Reves, and P N Samuelson
June 2002, Asian cardiovascular & thoracic annals,
J K Kirklin, and D E Chenoweth, and D C Naftel, and E H Blackstone, and J W Kirklin, and D D Bitran, and J G Curd, and J G Reves, and P N Samuelson
March 1981, Cardiovascular diseases,
Copied contents to your clipboard!